Growth hormone enhances thymic function in HIV-1-infected adults

Laura A. Napolitano, Diane Schmidt, Michael Gotway, Niloufar Ameli, Erin L. Filbert, Myra M. Ng, Julie L. Clor, Lorrie Epling, Elizabeth Sinclair, Paul D. Baum, Kai Li, Marisela Lua Killian, Peter Bacchetti, Joseph M. McCune

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Growth hormone (GH) is an underappreciated but important regulator of T cell development that can reverse age-related declines in thymopoiesis in rodents. Here, we report findings of a prospective randomized study examining the effects of GH on the immune system of HIV-1-infected adults. GH treatment was associated with increased thymic mass. In addition, GH treatment enhanced thymic output, as measured by both the frequency of T cell receptor rearrangement excision circles in circulating T cells and the numbers of circulating naive and total CD4+ T cells. These findings provide compelling evidence that GH induces de novo T cell production and may, accordingly, facilitate CD4+ T cell recovery in HIV-1-infected adults. Further, these randomized, prospective data have shown that thymic involution can be pharmacologically reversed in humans, suggesting that immune-based therapies could be used to enhance thymopoiesis in immunodeficient individuals.

Original languageEnglish (US)
Pages (from-to)1085-1098
Number of pages14
JournalJournal of Clinical Investigation
Volume118
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

Growth Hormone
HIV-1
T-Lymphocytes
T-Cell Antigen Receptor
Immune System
Rodentia
Cell Count
Prospective Studies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Napolitano, L. A., Schmidt, D., Gotway, M., Ameli, N., Filbert, E. L., Ng, M. M., ... McCune, J. M. (2008). Growth hormone enhances thymic function in HIV-1-infected adults. Journal of Clinical Investigation, 118(3), 1085-1098. https://doi.org/10.1172/JCI32830

Growth hormone enhances thymic function in HIV-1-infected adults. / Napolitano, Laura A.; Schmidt, Diane; Gotway, Michael; Ameli, Niloufar; Filbert, Erin L.; Ng, Myra M.; Clor, Julie L.; Epling, Lorrie; Sinclair, Elizabeth; Baum, Paul D.; Li, Kai; Killian, Marisela Lua; Bacchetti, Peter; McCune, Joseph M.

In: Journal of Clinical Investigation, Vol. 118, No. 3, 03.2008, p. 1085-1098.

Research output: Contribution to journalArticle

Napolitano, LA, Schmidt, D, Gotway, M, Ameli, N, Filbert, EL, Ng, MM, Clor, JL, Epling, L, Sinclair, E, Baum, PD, Li, K, Killian, ML, Bacchetti, P & McCune, JM 2008, 'Growth hormone enhances thymic function in HIV-1-infected adults', Journal of Clinical Investigation, vol. 118, no. 3, pp. 1085-1098. https://doi.org/10.1172/JCI32830
Napolitano, Laura A. ; Schmidt, Diane ; Gotway, Michael ; Ameli, Niloufar ; Filbert, Erin L. ; Ng, Myra M. ; Clor, Julie L. ; Epling, Lorrie ; Sinclair, Elizabeth ; Baum, Paul D. ; Li, Kai ; Killian, Marisela Lua ; Bacchetti, Peter ; McCune, Joseph M. / Growth hormone enhances thymic function in HIV-1-infected adults. In: Journal of Clinical Investigation. 2008 ; Vol. 118, No. 3. pp. 1085-1098.
@article{f0fbc06715cd4056b759c1eeab57d591,
title = "Growth hormone enhances thymic function in HIV-1-infected adults",
abstract = "Growth hormone (GH) is an underappreciated but important regulator of T cell development that can reverse age-related declines in thymopoiesis in rodents. Here, we report findings of a prospective randomized study examining the effects of GH on the immune system of HIV-1-infected adults. GH treatment was associated with increased thymic mass. In addition, GH treatment enhanced thymic output, as measured by both the frequency of T cell receptor rearrangement excision circles in circulating T cells and the numbers of circulating naive and total CD4+ T cells. These findings provide compelling evidence that GH induces de novo T cell production and may, accordingly, facilitate CD4+ T cell recovery in HIV-1-infected adults. Further, these randomized, prospective data have shown that thymic involution can be pharmacologically reversed in humans, suggesting that immune-based therapies could be used to enhance thymopoiesis in immunodeficient individuals.",
author = "Napolitano, {Laura A.} and Diane Schmidt and Michael Gotway and Niloufar Ameli and Filbert, {Erin L.} and Ng, {Myra M.} and Clor, {Julie L.} and Lorrie Epling and Elizabeth Sinclair and Baum, {Paul D.} and Kai Li and Killian, {Marisela Lua} and Peter Bacchetti and McCune, {Joseph M.}",
year = "2008",
month = "3",
doi = "10.1172/JCI32830",
language = "English (US)",
volume = "118",
pages = "1085--1098",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Growth hormone enhances thymic function in HIV-1-infected adults

AU - Napolitano, Laura A.

AU - Schmidt, Diane

AU - Gotway, Michael

AU - Ameli, Niloufar

AU - Filbert, Erin L.

AU - Ng, Myra M.

AU - Clor, Julie L.

AU - Epling, Lorrie

AU - Sinclair, Elizabeth

AU - Baum, Paul D.

AU - Li, Kai

AU - Killian, Marisela Lua

AU - Bacchetti, Peter

AU - McCune, Joseph M.

PY - 2008/3

Y1 - 2008/3

N2 - Growth hormone (GH) is an underappreciated but important regulator of T cell development that can reverse age-related declines in thymopoiesis in rodents. Here, we report findings of a prospective randomized study examining the effects of GH on the immune system of HIV-1-infected adults. GH treatment was associated with increased thymic mass. In addition, GH treatment enhanced thymic output, as measured by both the frequency of T cell receptor rearrangement excision circles in circulating T cells and the numbers of circulating naive and total CD4+ T cells. These findings provide compelling evidence that GH induces de novo T cell production and may, accordingly, facilitate CD4+ T cell recovery in HIV-1-infected adults. Further, these randomized, prospective data have shown that thymic involution can be pharmacologically reversed in humans, suggesting that immune-based therapies could be used to enhance thymopoiesis in immunodeficient individuals.

AB - Growth hormone (GH) is an underappreciated but important regulator of T cell development that can reverse age-related declines in thymopoiesis in rodents. Here, we report findings of a prospective randomized study examining the effects of GH on the immune system of HIV-1-infected adults. GH treatment was associated with increased thymic mass. In addition, GH treatment enhanced thymic output, as measured by both the frequency of T cell receptor rearrangement excision circles in circulating T cells and the numbers of circulating naive and total CD4+ T cells. These findings provide compelling evidence that GH induces de novo T cell production and may, accordingly, facilitate CD4+ T cell recovery in HIV-1-infected adults. Further, these randomized, prospective data have shown that thymic involution can be pharmacologically reversed in humans, suggesting that immune-based therapies could be used to enhance thymopoiesis in immunodeficient individuals.

UR - http://www.scopus.com/inward/record.url?scp=40549089870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549089870&partnerID=8YFLogxK

U2 - 10.1172/JCI32830

DO - 10.1172/JCI32830

M3 - Article

VL - 118

SP - 1085

EP - 1098

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -